Chordoma is a rare, slow-growing, locally aggressive, primary bone tumor that arises from the skull base region in approximately 25–35% of cases. The therapeutic approach to chordoma has traditionally been surgery, followed by radiation therapy. The advent of charged particle radiotherapy has let us consider protons as the postoperative treatment of choice, but no controlled studies have yet confirmed the superiority of protons over photons. During January 2008, two independent researchers conducted a systematic review of the current data on the treatment of base of the skull chordoma C with proton therapy (PT) and, for comparison, with other irradiation techniques (conventional radiation therapy, ion therapy, fractionated stereotactic radiation therapy, and radiosurgery). Two hundred and ten reports in total were retrieved (81 concerning PT). According to the inclusion criteria, 47 articles were considered in the analysis. There were no prospective trials (randomized or nonrandomized) but just seven uncontrolled single-arm studies for PT, providing clinical outcomes for 416 patients in total; these reports were mainly related to advanced inoperable or incompletely resected tumors. The therapeutic approach to chordoma of the base of the skull has traditionally relied on surgical control. Radiation therapy has demonstrated to be a valuable modality for local control in the postoperative setting, particularly with the advent of charged particle radiotherapy. The use of protons has shown better results in comparison to the use of conventional photon irradiation, resulting in the best long-term (10 years) outcome for this tumor with relatively few significant complications considering the high doses delivered with this therapeutic modality.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Al-Mefty O, Borba LA (1997) Skull base chordomas: a management challenge. J Neurosurg 86:182–189
Amendola BE, Amendola MA, Oliver E, McClatchey KD (1986) Chordoma: role of radiation therapy. Radiology 158:839–843
Austin JP, Urie MM, Cardenosa G, Munzenrider JE (1993) Probable causes of recurrence in patients with chordoma and chondrosarcoma of the base of skull and cervical spine. Int J Radiat Oncol Biol Phys 25:439–444
Austin-Seymour M, Munzenrider J, Goitein M, Verhey L, Urie M, Gentry R, Birnbaum S, Ruotolo D, McManus P, Skates S et al (1989) Fractionated proton radiation therapy of chordoma and low-grade chondrosarcoma of the base of the skull. J Neurosurg 70:13–17
Barnes L (1994) The biology and pathology of selected skull base tumors. J Neurooncol 20:213–240
Benk V, Liebsch NJ, Munzenrider JE, Efird J, McManus P, Suit H (1995) Base of skull and cervical spine chordomas in children treated by high-dose irradiation. Int J Radiat Oncol Biol Phys 31:577–581
Berson AM, Castro JR, Petti P, Phillips TL, Gauger GE, Gutin P, Collier JM, Henderson SD, Baken K (1988) Charged particle irradiation of chordoma and chondrosarcoma of the base of skull and cervical spine: the Lawrence Berkeley Laboratory experience. Int J Radiat Oncol Biol Phys 15:559–565
Borba LA, Al-Mefty O, Mrak RE, Suen J (1996) Cranial chordomas in children and adolescents. J Neurosurg 84:584–591
Boriani S, Bandiera S, Biagini R, Bacchini P, Boriani L, Cappuccio M, Chevalley F, Gasbarrini A, Picci P, Weinstein JN (2006) Chordoma of the mobile spine: fifty years of experience. Spine 31:493–503
Brada M, Pijls-Johannesma M, De Ruysscher D (2007) Proton therapy in clinical practice: current clinical evidence. J Clin Oncol 25:965–970
Castro JR, Linstadt DE, Bahary JP, Petti PL, Daftari I, Collier JM, Gutin PH, Gauger G, Phillips TL (1994) Experience in charged particle irradiation of tumors of the skull base: 1977–1992. Int J Radiat Oncol Biol Phys 29:647–655
Catton C, O'Sullivan B, Bell R, Laperriere N, Cummings B, Fornasier V, Wunder J (1996) Chordoma: long-term follow-up after radical photon irradiation. Radiother Oncol 41:67–72
Chang SD, Martin DP, Lee E, Adler JR Jr (2001) Stereotactic radiosurgery and hypofractionated stereotactic radiotherapy for residual or recurrent cranial base and cervical chordomas. Neurosurg Focus 10:E5
Chetiyawardana AD (1984) Chordoma: results of treatment. Clin Radiol 35:159–161
Cho YH, Kim JH, Khang SK, Lee JK, Kim CJ (2008) Chordomas and chondrosarcomas of the skull base: comparative analysis of clinical results in 30 patients. Neurosurg Rev 31:35–43
Colli B, Al-Mefty O (2001) Chordomas of the craniocervical junction: follow-up review and prognostic factors. J Neurosurg 95:933–943
Colli B, Al-Mefty O (2001) Chordomas of the skull base: follow-up review and prognostic factors. Neurosurg Focus 10:111
Crockard A, Macaulay E, Plowman PN (1999) Stereotactic radiosurgery. VI. Posterior displacement of the brainstem facilitates safer high dose radiosurgery for clival chordoma. Br J Neurosurg 13:65–70
Cummings BJ, Hodson DI, Bush RS (1983) Chordoma: the results of megavoltage radiation therapy. Int J Radiat Oncol Biol Phys 9:633–642
Debus J, Hug EB, Liebsch NJ, O'Farrel D, Finkelstein D, Efird J, Munzenrider JE (1997) Brainstem tolerance to conformal radiotherapy of skull base tumors. Int J Radiat Oncol Biol Phys 39:967–975
Debus J, Schulz-Ertner D, Schad L, Essig M, Rhein B, Thillmann CO, Wannenmacher M (2000) Stereotactic fractionated radiotherapy for chordomas and chondrosarcomas of the skull base. Int J Radiat Oncol Biol Phys 47:591–596
Feuvret L, Noel G, Weber DC, Pommier P, Ferrand R, De Marzi L, Dhermain F, Alapetite C, Mammar H, Boisserie G, Habrand JL, Mazeron JJA (2007) Treatment planning comparison of combined photon–proton beams versus proton beams-only for the treatment of skull base tumors. Int J Radiat Oncol Biol Phys 69:944–954
Forsyth PA, Cascino TL, Shaw EG, Scheithauer BW, O'Fallon JR, Dozier JC, Piepgras DG (1993) Intracranial chordomas: a clinicopathological and prognostic study of 51 cases. J Neurosurg 78:741–747
Fuller DB, Bloom JG (1988) Radiotherapy for chordoma. Int J Radiat Oncol Biol Phys 15:331–339
Gay E, Sekhar LN, Rubinstein E, Wright DC, Sen C, Janecka IP, Snyderman CH (1995) Chordomas and chondrosarcomas of the cranial base: results and follow-up of 60 patients. Neurosurgery 36:887–896
Gwak HS, Yoo HJ, Youn SM, Chang U, Lee DH, Yoo SY, Rhee CH (2005) Hypofractionated stereotactic radiation therapy for skull base and upper cervical chordoma and chondrosarcoma: preliminary results. Stereotact Funct Neurosurg 83:233–243
Harsh GF (2001) Chordomas and chondrosarcomas of the skull base. In: Kaye AH, Laws ER (eds) Brain tumors. Churchill Livingstone, London, pp 857–869
Hasegawa T, Ishii D, Kida Y, Yoshimoto M, Koike J, Iizuka H (2007) Gamma knife surgery for skull base chordomas and chondrosarcomas. J Neurosurg 107:752–757
Hoch BL, Nielsen GP, Liebsch NJ, Rosemberg AE (2006) Base of skull chordoma in children and adolescents: a clinicopathologic study of 73 cases. Am J Surg Pathol 30:811–818
Hug EB (2000) Proton radiation therapy for chordomas and chondrosarcomas of the skull base. Neurosurg Clin N Am 11:627–638
Hug E, Loredo LN, Slater JD, DeVries A, Grove RI, Schaefer RA, Rosenberg AE, Slater JM (1999) Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg 91:432–439
Hug EB, Sweeney RA, Nurre PM, Holloway KC, Slater JD, Munzenrider JE (2002) Proton radiotherapy in management of pediatric base of skull tumors. Int J Radiat Oncol Biol Phys 52:1017–1024
Igaki H, Tokuuye K, Okumura T, Sugahara S, Kagei K, Hata M, Ohara K, Hashimoto T, Tsuboi K, Takano S, Matsumura A, Akine Y (2004) Clinical results of proton beam therapy for skull base chordoma. Int J Radiat Oncol Biol Phys 60:1120–1126
Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics (2007). CA Cancer J Clin 57:43–66
Keisch ME, Garcia DM, Shibuya RB (1991) Retrospective long-term follow-up analysis in 21 patients with chordomas of various sites treated at a single institution. J Neurosurg 75(3):74–377
Khairi S, Ewend MG (2002) Chordoma. Curr Treat Options Neurol 4:167–173
Kondziolka D, Lunsford LD, Flickinger JC (1991) The role of radiosurgery in the management of chordoma and chondrosarcoma of the cranial base. Neurosurgery 29:38–45
Krishnan S, Foote RL, Brown PD, Pollock BE, Link MJ, Garces YI (2005) Radiosurgery for cranial base chordomas and chondrosarcomas. Neurosurgery 56:777–784
Lodge M, Pijls-Johannesma M, Stirk L, Munro AJ, De Ruysscher D, Jefferson T (2007) A systematic literature review of the clinical and cost-effectiveness of hadron therapy in cancer. Radiother Oncol 83:110–122
Lybeert ML, Meerwaldt JH (1986) Chordoma. Report on treatment results in eighteen cases. Acta Radiol Oncol 25:41–43
Martin JJ, Niranjan A, Kondziolka D, Flickinger JC, Lozanne KA, Lunsford LD (2007) Radiosurgery for chordomas and chondrosarcomas of the skull base. J Neurosurg 107:758–764
McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM (2001) Chordoma: incidence and survival patterns in the United States, 1973–1995. Cancer Causes Control 12:1–11
Mendenhall WM, Mendenhall CM, Lewis SB, Villaret DB, Mendenhall NP (2005) Skull base chordoma. Head Neck 27:159–165
Menezes AH, Gantz BJ, Traynelis VC, McCulloch TM (1997) Cranial base chordomas. Clin Neurosurg 44:491–509
Miller RC, Foote RL, Coffey RJ, Gorman DA, Earle JD, Schomberg PJ, Kline RW (1997) The role of stereotactic radiosurgery in the treatment of malignant skull base tumors. Int J Radiat Oncol Biol Phys 39:977–981
Mirra J, Nelson S, Della Rocca C et al (2002) In: Fletcher CD, Unni K, Mertens F (eds) Pathology and genetics of tumours of soft tissue and bone. Chordoma. IARC Press, Lyon, pp 316–317
Monfared A, Agrawal S, Jackler RK (2007) Cranial base approaches to inaccessible intracranial tumors. Curr Opin Neurol 20:726–731
Munzenrider JE, Liebsch NJ (1999) Proton therapy for tumors of the skull base. Strahlenther Onkol 175(Suppl II):57–63
Muthukumar N, Kondziolka D, Lunsford LD, Flickinger JC (1998) Stereotactic radiosurgery for chordoma and chondrosarcoma: further experiences. Int J Radiat Oncol Biol Phys 41:387–392
Newton HB (2006) Chordomas. In: Raghavan D, Brecher ML, Johnson DH, Meropol NJ, Moots PL, Rose PG, Mayer DA (eds) Textbook of uncommon cancer, 3rd edn. Wiley, Chichester, pp 614–625
NHS Centre for Review and Dissemination (2001) Undertaking systematic reviews of research on effectiveness. NHS CRD, York
Noël G, Feuvret L, Calagaru V, Dhermain F, Mammar H, Haie-Méder C, Ponvert D, Hasboun D, Ferrand R, Nauraye C, Boisserie G, Beaudré A, Gaboriaud G, Mazal A, Habrand JL, Mazeron JJ (2005) Chordomas of the spine and upper cervical spine. One hundred patients irradiated by a 3D conformal technique combining photon and proton beams. Acta Oncol 44:700–708
Olsen DR, Bruland OS, Frykholm G, Norderhaug IN (2007) Proton therapy—a systematic review of clinical effectiveness. Radiother Oncol 83:123–132
Pai HH, Thornton A, Katznelson L, Finkelstein DM, Adams JA, Fullerton BC, Loeffler JS, Leibsch NJ, Klibanski A, Munzenrider JE (2001) Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose–effect relationship using dose–volume histogram analysis. Int J Radiat Oncol Biol Phys 49:1079–1092
Pearlman AW, Friedman M (1970) Radical radiation therapy of chordoma. Am J Roentgenol Radium Ther Nucl Med 108:332–341
Raffel C, Wright DC, Gutin PH, Wilson CB (1985) Cranial chordomas: clinical presentation and results of operative and radiation therapy in twenty-six patients. Neurosurgery 17:703–710
Reddy EK, Mansfield CM, Hartman GV (1981) Chordoma. Int J Radiat Oncol Biol Phys 7:1709–1711
Rich TA, Schiller A, Suit HD, Mankin HJ (1985) Clinical and pathologic review of 48 cases of chordoma. Cancer 56:182–187
Romero J, Cardenes H, la Torre A, Valcarcel F, Magallon R, Regueiro C, Aragon G (1993) Chordoma: results of radiation therapy in eighteen patients. Radiother Oncol 29:27–32
Santoni R, Liebsch N, Finkelstein DM, Hug E, Hanssens P, Goitein M, Smith AR, O'Farrell D, Efird JT, Fullerton B, Munzenrider JE (1998) Temporal lobe (TL) damage following surgery and high-dose photon and proton irradiation in 96 patients affected by chordomas and chondrosarcomas of the base of the skull. Int J Radiat Oncol Biol Phys 41:59–68
Saunders WM, Chen GT, Austin-Seymour M, Castro JR, Collier JM, Gauger G, Gutin P, Phillips TL, Pitluck S, Walton RE et al (1985) Precision, high dose radiotherapy. II. Helium ion treatment of tumors adjacent to critical central nervous system structures. Int J Radiat Oncol Biol Phys 11:1339–1347
Schulz-Ertner D, Karger CP, Feuerhake A, Nikoghosyan A, Combs SE, Jäkel O, Edler L, Scholz M, Debus J (2007) Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas. Int J Radiat Oncol Biol Phys 68:449–457
Sekhar LN (1996) Neurosurgery. In: Rengachary SS (ed) Wilkins R. McGraw-Hill, New York, pp 1529–1541
Sekhar LN, Pranatartiharan R, Chanda A, Wright DC (2001) Chordomas and chondrosarcomas of the skull base: results and complications of surgical management. Neurosurg Focus 10:E2
Slater JM (1995) Proton therapy for cranial base tumors. J Craniofac Surg 6:24–26
Suit HD, Goitein M, Munzenrider J, Verhey L, Davis KR, Koehler A, Linggood R, Ojemann RG (1982) Definitive radiation therapy for chordoma and chondrosarcoma of base of skull and cervical spine. J Neurosurg 56:377–385
Tai PT, Craighead P, Bagdon F (1995) Optimization of radiotherapy for patients with cranial chordoma. A review of dose–response ratios for photon techniques. Cancer 75:749–756
Terahara A, Niemierko A, Goitein M, Finkelstein D, Hug E, Liebsch N, O'Farrell D, Lyons S, Munzenrider J (1999) Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma. Int J Radiat Oncol Biol Phys 45:351–358
Tewfik HH, McGinnis WL, Nordstrom DG, Latourette HB (1977) Chordoma: evaluation of clinical behavior and treatment modalities. Int J Radiat Oncol Biol Phys 2:959–962
Tsai EC, Santoreneos S, Rutka JT (2002) Tumors of the skull base in children: review of tumor types and management strategies. Neurosurg Focus 12:e1
Tsujii H, Mizoe J, Kamada T, Baba M, Tsuji H, Kato H, Kato S, Yamada S, Yasuda S, Ohno T, Yanagi T, Imai R, Kagei K, Kato H, Hara R, Hasegawa A, Nakajima M, Sugane N, Tamaki N, Takagi R, Kandatsu S, Yoshikawa K, Kishimoto R, Miyamoto T (2007) Clinical results of carbon ion radiotherapy at NIRS. J Radiat Res 48(suppl. 2):A1–A13
Tzortzidis F, Elahi F, Wright D, Natarajan SK, Sekhar LN (2006) Patient outcome at long-term follow-up after aggressive microsurgical resection of cranial base chordomas. Neurosurgery 59:230–237
Urie MM, Fullerton B, Tatsuzaki H, Birnbaum S, Suit HD, Convery K, Skates S, Goitein M (1992) A dose response analysis of injury to cranial nerves and/or nuclei following proton beam radiation therapy. Int J Radiat Oncol Biol Phys 23:27–39
Verhey LJ, Smith V, Serago CF (1998) Comparison of radiosurgery treatment modalities based on physical dose distributions. Int J Radiat Oncol Biol Phys 40:497–505
Watkins L, Khudados ES, Kaleoglu M, Revesz T, Sacares P, Crockard HA (1993) Skull base chordomas: a review of 38 patients, 1958–88. Br J Neurosurg 7:241–248
Weber DC, Rutz HP, Pedroni ES, Bolsi A, Timmermann B, Verwey J, Lomax AJ, Goitein G (2005) Results of spot-scanning proton radiation therapy for chordoma and chondrosarcoma of the skull base: the Paul Scherrer institute experience. Int J Radiat Oncol Biol Phys 63:401–409
Zorlu F, Gürkaynak M, Yildiz F, Oge K, Atahan IL (2000) Conventional external radiotherapy in the management of clivus chordomas with overt residual disease. Neurol Sci 21:203–207
Ladislau Steiner, Chun-Po Yen, Charlottesville, USA
Amichetti et al. conducted a systematic review of the current data on the treatment of skull base chordomas with proton therapy and compared the imaging and clinical outcomes to those following fractionated photon radiation, ion therapy, fractionated stereotactic photon therapy, and radiosurgery.
The Medline literature search was restricted to articles published in English between January 1980 and January 2008. Of 210 reports, 81 addressed proton treatment. Using the guidelines of the National Institute of Health for systematic reviews of research on effectiveness, 47 articles were selected according to the following criteria (1) series with at least ten patients and (2) at least 24 months of follow-up. Twenty articles with data that were updated in later versions were eliminated leaving 27 articles for final analysis.
Selected series were: (1) seven proton therapy articles with a total of 416 patients; these were all retrospective and no randomized phase I or II studies; the largest series was from the Francis Burr Therapy Center at Massachusetts General Hospital, Boston with 169 patients; (2) ten studies with 141 patients undergoing conventional fractionated photon radiotherapy; (3) one publication on stereotactic fractionated radiation therapy with 45 patients; (4) five studies on radiosurgery with a total of 109 patients; (5) a total of 206 patients in four studies on ion therapy.
The authors meticulously assessed the content of the reviewed articles; however, their tables are difficult to read. Commenting the results of the different treatment modalities, they emphasized the inherent bias of retrospective analysis of small number of patients treated over many years and the fact that some patients were treated before the advent of megavoltage linear accelerators and/or the introduction of the CT scan. They insisted on the pitfalls when discussing cases with various treatment policies that sometimes there were no tissue diagnosis and/or sufficient details on radiotherapy techniques. They also warned of flaws in comparing relatively large series of proton therapy with long track record to small series of other kind of radiations with shorter periods of follow-up. They emphasized that mostly uncontrolled evidence supports the clinical advantages of proton as compared to conventional photon therapy and that, in order to evaluate the long-term efficacy of proton treatment in chordomas, it should be kept in mind that only Munzenrider et al. reported on long-term survival in 10 years of follow-up. Furthermore, superiority in terms of local control using proton has been demonstrated versus conventional photon therapy only.
It is pertinent to the authors' observation that a great part of the data in proton therapy included patients referred to treatment using cyclotrons in physics departments with suboptimal techniques as compared to the technology in today's proton units dedicated to treatment of patients.
Mentioning as a drawback the absence of cell repair during radiosurgery, Amichetti et al. failed to explain that not cell repair during sublethal dose delivery but the radiological effects induced by the steep dose gradients at the edge of the target defines the advantages of radiosurgery.
The advantage of proton due to its characteristic high-dose region at the end of the particle range (Bragg peak) is common knowledge. However, the statements of Amichetti et al. that the planning technique of the proton therapy is superior to that used in gamma knife procedures and that in irregular-shaped tumors the proton treatment plan is more conformal than that achieved with gamma knife may be taken with a grain of salt. Concerning the advantage of the proton treatment in large chordomas, there is a consensus today that, without radical surgery resulting in small tumor residuals, no radiation modality can successfully manage a chordoma. Or, if this is the case, it is not relevant whether a method may cover larger tumor volumes as compared to other radiation modalities.
Finally, illustrations of one case of chordoma treated by us at the Lars Leksell Center for gamma surgery in the Department of Neurosurgery, University of Virginia, may serve as a caveat against hasty conclusions before mature data are available.
A. R. a 45-year-old gentleman with skull base chordoma was treated with gamma surgery on October 19, 1994. The size of the tumor progressively decreased. However, after 5 years, recurrence occurred. At the time of retreatment with gamma surgery, the tumor measured 3 cm3 on enhanced T1-weighted magnetic resonance imaging (MRI; A). It did shrink progressively and, after close to 9 years, measured 0.1 cm3 (90% decrease) on enhanced T1-weighted MRI (B).
About this article
Cite this article
Amichetti, M., Cianchetti, M., Amelio, D. et al. Proton therapy in chordoma of the base of the skull: a systematic review. Neurosurg Rev 32, 403 (2009). https://doi.org/10.1007/s10143-009-0194-4
- Systematic review
- Base of the skull
- Proton therapy